Effect of cholinesterase inhibitors in hysteric stupor
Ikonomoff, S.I.
Münchener Medizinische Wochenschrift 115(16): 701-703
1973
ISSN/ISBN: 0341-3098 PMID: 4740414 Document Number: 59614
Document emailed within 1 workday
Related Documents
Leeuwin, R.S. 1984: Interactions of cholinesterase inhibitors and corticosteroids with the hypnotic effect of benzodiazepines in mice Archives Internationales de Pharmacodynamie et de Therapie 269(1): 34-41Petroianu, G.A.; Moshnin, W. 2008: The history of cholinesterase inhibitors: who was Moschnin(e)? Die Pharmazie 63(4): 325-327
Hitzeman, N. 2006: Cholinesterase inhibitors for Alzheimer's disease American Family Physician 74(5): 747-749
Borchert, K.; Pietsch, P.; Busch, H. 1972: Use of cholinesterase inhibitors in postoperative care Zentralblatt für Chirurgie 97(4): 111-116
Ellis, J.M. 2005: Cholinesterase inhibitors in the treatment of dementia Journal of the American Osteopathic Association 105(3): 145-158
Vasenina, E.E. 2013: Cholinesterase inhibitors in the treatment of mixed dementia Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(7 Part 2): 98-103
Tonkopiĭ, V.D. 1975: Mechanism of the hypothermic action of reversible cholinesterase inhibitors Farmakologiia i Toksikologiia 38(2): 141-144
Sinforiani, E.; Banchieri, L.M.; Zucchella, C.; Bernasconi, L.; Nappi, G. 2003: Cholinesterase inhibitors in Alzheimer's disease: efficacy in a non-selected population Functional Neurology 18(4): 233-237
Balashova, E.K.; Pevzner, D.L.; Rozengart, V.I.; Sherstobitov, O.E. 1974: Determination of hydrophobic organic phosphorus cholinesterase inhibitors in the blood Laboratornoe Delo 12: 719-720
Gindilis, A.L.; Kurochkin, I.N. 1998: Potentiometric electrodes for determining choline, butyrylcholine and cholinesterase inhibitors Prikladnaia Biokhimiia i Mikrobiologiia 34(3): 326-331
Zhang, S.S.; Ji, Q.E. 1987: Synthesis of 5-(1,3,3-trisubstituted) indolinyl-N,N-dimethylcarbamates as reversible cholinesterase inhibitors Yao Xue Xue Bao 22(2): 107-113
Richard, E.; van Gool, W.A. 2006: Cholinesterase inhibitors in dementia: the precarious balance between efficacy and safety Nederlands Tijdschrift Voor Geneeskunde 150(10): 530-532
Natoff, I.L. 1970: Influence of the route of exposure on the acute toxicity of cholinesterase inhibitors Arhiv Za Higijenu Rada i Toksikologiju 21(4): 347-352
Graipaspong, N.; Thaipisuttikul, P.; Vallipakorn, S.A.-O. 2016: Cholinesterase Inhibitors and Behavioral and Psychological Symptoms of Alzheimer's Disease Journal of the Medical Association of Thailand 99(4): 433-440
Williamson, A.M.; Sarvey, J.M. 1985: Effects of cholinesterase inhibitors on evoked responses in field CA1 of the rat hippocampus Journal of Pharmacology and Experimental Therapeutics 235(2): 448-455
Rösler, M. 2002: The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia International Journal of Clinical Practice. Suppl 127: 20-36
Crismon, M.L. 1998: Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease PharmacoTherapy 18(2 Part 2): 47-54; Discussion: 79-82
Farlow, M.R. 2002: Cholinesterase inhibitors: relating pharmacological properties to clinical profiles: Introduction International journal of clinical practice. Supplement 2002(127): 1-5
Larsson, A. 2006: Good evidence for benefits of cholinesterase inhibitors in Parkinson dementia is still missing Lakartidningen 103(19): 1537; Discussion: 1537-1538
Turov, M.I.; Smusin, I.S.; Babakhanian, R.V. 1975: Rate of disappearance of cholinesterase inhibitors from the circulating blood as dependent on their chemical structure Zhurnal Eksperimental'noi i Klinicheskoi Meditsiny 15(2): 21-24